JPH0118051B2 - - Google Patents
Info
- Publication number
- JPH0118051B2 JPH0118051B2 JP55042598A JP4259880A JPH0118051B2 JP H0118051 B2 JPH0118051 B2 JP H0118051B2 JP 55042598 A JP55042598 A JP 55042598A JP 4259880 A JP4259880 A JP 4259880A JP H0118051 B2 JPH0118051 B2 JP H0118051B2
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- aqueous solution
- dissolution
- water
- observed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000011734 sodium Substances 0.000 claims description 36
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 20
- 229910052708 sodium Inorganic materials 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- DQDZQHMCPDUUPC-UHFFFAOYSA-N Sulfadimethoxine sodium Chemical compound [Na+].COC1=NC(OC)=CC([N-]S(=O)(=O)C=2C=CC(N)=CC=2)=N1 DQDZQHMCPDUUPC-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229910021538 borax Inorganic materials 0.000 claims description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004327 boric acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 239000004328 sodium tetraborate Substances 0.000 claims description 3
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 3
- 229960000703 sulfadimethoxine sodium Drugs 0.000 claims description 3
- 235000010338 boric acid Nutrition 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- IZJAOWYNDLDRKM-UHFFFAOYSA-N sodium;(4-aminophenyl)sulfonyl-(6-methoxypyrimidin-4-yl)azanide Chemical compound [Na+].C1=NC(OC)=CC([N-]S(=O)(=O)C=2C=CC(N)=CC=2)=N1 IZJAOWYNDLDRKM-UHFFFAOYSA-N 0.000 claims 1
- 238000004090 dissolution Methods 0.000 description 15
- 238000001556 precipitation Methods 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000013078 crystal Substances 0.000 description 12
- 239000000654 additive Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013022 formulation composition Substances 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229960000973 sulfadimethoxine Drugs 0.000 description 3
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 208000003495 Coccidiosis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001470497 Leucocytozoon Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- AENYAMPVQFAKHY-UHFFFAOYSA-N boric acid;potassium Chemical compound [K].OB(O)O AENYAMPVQFAKHY-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4259880A JPS56139414A (en) | 1980-04-01 | 1980-04-01 | Stabilizing method of aqueous solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4259880A JPS56139414A (en) | 1980-04-01 | 1980-04-01 | Stabilizing method of aqueous solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56139414A JPS56139414A (en) | 1981-10-30 |
| JPH0118051B2 true JPH0118051B2 (ko) | 1989-04-03 |
Family
ID=12640486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4259880A Granted JPS56139414A (en) | 1980-04-01 | 1980-04-01 | Stabilizing method of aqueous solution |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56139414A (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950010150B1 (ko) * | 1986-01-14 | 1995-09-11 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 함유 주사제의 안정화 방법 |
| JPS6396126A (ja) * | 1986-10-13 | 1988-04-27 | Taisho Pharmaceut Co Ltd | 安定化組成物 |
| JPS63159317A (ja) * | 1986-12-24 | 1988-07-02 | Terumo Corp | アラントイン含有水性製剤 |
| CN1054127C (zh) * | 1996-07-16 | 2000-07-05 | 中国医药研究开发中心 | 磺胺－6－甲氧嘧啶一水合物的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4918670A (ko) * | 1972-06-14 | 1974-02-19 |
-
1980
- 1980-04-01 JP JP4259880A patent/JPS56139414A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4918670A (ko) * | 1972-06-14 | 1974-02-19 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56139414A (en) | 1981-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2735903B2 (ja) | イブプロフエン沸騰製剤 | |
| CA1040532A (en) | Process for producing solid bismuth-containing pharmaceutical compositions | |
| EP0011489B1 (en) | An analgesic effervescent powder and process for its preparation | |
| JP4804431B2 (ja) | 長時間作用オキシテトラサイクリン組成物 | |
| UA72541C2 (en) | A pharmaceutical composition containing benzamide derivative | |
| JPS584720A (ja) | 鎮痛用医薬組成物 | |
| JPH0347161A (ja) | ５―アミノサリチル酸の安定な液体形 | |
| JP2893140B2 (ja) | 安定なビタミンｄ製剤 | |
| US20080233196A1 (en) | Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles | |
| EP0154009A1 (en) | Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament | |
| SI21259A (sl) | Farmacevtski pripravki z antibiotičnim delovanjem | |
| US3621094A (en) | Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts | |
| JPH0118051B2 (ko) | ||
| US4128632A (en) | Solubilization of Rafoxanide | |
| JPS605567B2 (ja) | オキシテトラサイクリンの調合液 | |
| US4428951A (en) | Long acting pharmaceutical composition | |
| EP0159777A1 (en) | Stabilized 4-carbamoyl-imidazolium-5-olate | |
| RU2527042C1 (ru) | Биологически активная добавка к пище для профилактики заболеваний остеопорозом | |
| JP2594395B2 (ja) | アズレンスルホン酸ナトリウムの安定化法および製剤 | |
| JPS62126130A (ja) | 動物用医薬組成物 | |
| CA1154676A (en) | Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation | |
| US3592890A (en) | Method of combating atrophic rhinitis | |
| JP2002284679A (ja) | 安定な甲状腺ホルモン含有固形製剤組成物 | |
| JPS60260510A (ja) | ケトン症治療用の注射溶液 | |
| JPS5839625A (ja) | 経口家畜下痢治療用組成物 |